University of Hertfordshire

Standard

Major urological cancer surgery for patients is safe and surgical training should be encouraged during the COVID-19 pandemic : A multi-centre analysis of 30-day outcomes. / Tan, Wei Shen; Arianayagam, Ranjan; Khetrapal, Pramit; Rowe, Edward; Kearley, Samantha; Mahrous, Ahmed; Pal, Raj; Fowler, William; Heer, Rakesh; Elajnaf, Mohamed; Douglas-Moore, Jayne; Griffiths, TR Leyshon ; Voss, James; Wilby, Daniel; Al Kadhi, Omar; Noel, Jonathan; Vasdev, Nikhil; McKay, Alastair; Ahmad, Imran; Abu-Nayla, Islam; Lamb, Benjamin; Hill, George T; Narahari, Krishna; Kynaston, Howard; Yousuf, Arzu; Kusuma, Venkata RM; Cresswell, Joanne; Cooke, Pete; Chakravarti, Aniruddha; Barod, Ravi; Bex, Axel; Kelly, John D.

In: European Urology Open Science , Vol. 25, 03.2021, p. 39-43.

Research output: Contribution to journalLetterpeer-review

Harvard

Tan, WS, Arianayagam, R, Khetrapal, P, Rowe, E, Kearley, S, Mahrous, A, Pal, R, Fowler, W, Heer, R, Elajnaf, M, Douglas-Moore, J, Griffiths, TRL, Voss, J, Wilby, D, Al Kadhi, O, Noel, J, Vasdev, N, McKay, A, Ahmad, I, Abu-Nayla, I, Lamb, B, Hill, GT, Narahari, K, Kynaston, H, Yousuf, A, Kusuma, VRM, Cresswell, J, Cooke, P, Chakravarti, A, Barod, R, Bex, A & Kelly, JD 2021, 'Major urological cancer surgery for patients is safe and surgical training should be encouraged during the COVID-19 pandemic: A multi-centre analysis of 30-day outcomes', European Urology Open Science , vol. 25, pp. 39-43. https://doi.org/10.1016/j.euros.2021.01.005

APA

Tan, W. S., Arianayagam, R., Khetrapal, P., Rowe, E., Kearley, S., Mahrous, A., Pal, R., Fowler, W., Heer, R., Elajnaf, M., Douglas-Moore, J., Griffiths, TR. L., Voss, J., Wilby, D., Al Kadhi, O., Noel, J., Vasdev, N., McKay, A., Ahmad, I., ... Kelly, J. D. (2021). Major urological cancer surgery for patients is safe and surgical training should be encouraged during the COVID-19 pandemic: A multi-centre analysis of 30-day outcomes. European Urology Open Science , 25, 39-43. https://doi.org/10.1016/j.euros.2021.01.005

Vancouver

Author

Tan, Wei Shen ; Arianayagam, Ranjan ; Khetrapal, Pramit ; Rowe, Edward ; Kearley, Samantha ; Mahrous, Ahmed ; Pal, Raj ; Fowler, William ; Heer, Rakesh ; Elajnaf, Mohamed ; Douglas-Moore, Jayne ; Griffiths, TR Leyshon ; Voss, James ; Wilby, Daniel ; Al Kadhi, Omar ; Noel, Jonathan ; Vasdev, Nikhil ; McKay, Alastair ; Ahmad, Imran ; Abu-Nayla, Islam ; Lamb, Benjamin ; Hill, George T ; Narahari, Krishna ; Kynaston, Howard ; Yousuf, Arzu ; Kusuma, Venkata RM ; Cresswell, Joanne ; Cooke, Pete ; Chakravarti, Aniruddha ; Barod, Ravi ; Bex, Axel ; Kelly, John D. / Major urological cancer surgery for patients is safe and surgical training should be encouraged during the COVID-19 pandemic : A multi-centre analysis of 30-day outcomes. In: European Urology Open Science . 2021 ; Vol. 25. pp. 39-43.

Bibtex

@article{e306d2f0c4744e7c81a06f2538247cdf,
title = "Major urological cancer surgery for patients is safe and surgical training should be encouraged during the COVID-19 pandemic: A multi-centre analysis of 30-day outcomes",
abstract = "COVID-19 has resulted in the deferral of major surgery for genitourinary (GU) cancers with the exception of cancers with a high risk of progression. We report outcomes for major GU cancer operations, namely radical prostatectomy (RP), radical cystectomy (RC), radical nephrectomy (RN), partial nephrectomy (PN), and nephroureterectomy performed at 13 major GU cancer centres across the UK between March 1 and May 5, 2020. A total of 598 such operations were performed. Four patients (0.7%) developed COVID-19 postoperatively. There was no COVID-19–related mortality at 30 d. A minimally invasive approach was used in 499 cases (83.4%). A total of 228 cases (38.1%) were described as training procedures. Training case status was not associated with a higher American Society of Anesthesiologists (ASA) score (p = 0.194) or hospital length of stay (LOS; p > 0.05 for all operation types). The risk of contracting COVID-19 was not associated with longer hospital LOS (p = 0.146), training case status (p = 0.588), higher ASA score (p = 0.295), or type of hospital site (p = 0.303). Our results suggest that major surgery for urological cancers remains safe and training should be encouraged during the ongoing COVID-19 pandemic provided appropriate countermeasures are taken. These real-life data are important for policy-makers and clinicians when counselling patients during the current pandemic. Patient summary: We collected outcome data for major operations for prostate, bladder, and kidney cancers during the COVID-19 pandemic. These surgeries remain safe and training should be encouraged during the ongoing pandemic provided appropriate countermeasures are taken. Our real-life results are important for policy-makers and clinicians when counselling patients during the COVID-19 pandemic.",
keywords = "COVID-19, Cystectomy, Mortality, Nephrectomy, Outcomes, Prostatectomy",
author = "Tan, {Wei Shen} and Ranjan Arianayagam and Pramit Khetrapal and Edward Rowe and Samantha Kearley and Ahmed Mahrous and Raj Pal and William Fowler and Rakesh Heer and Mohamed Elajnaf and Jayne Douglas-Moore and Griffiths, {TR Leyshon} and James Voss and Daniel Wilby and {Al Kadhi}, Omar and Jonathan Noel and Nikhil Vasdev and Alastair McKay and Imran Ahmad and Islam Abu-Nayla and Benjamin Lamb and Hill, {George T} and Krishna Narahari and Howard Kynaston and Arzu Yousuf and Kusuma, {Venkata RM} and Joanne Cresswell and Pete Cooke and Aniruddha Chakravarti and Ravi Barod and Axel Bex and Kelly, {John D}",
note = "Funding Information: Funding/Support and role of the sponsor: Wei Shen Tan is funded by the Urology Foundation . Publisher Copyright: {\textcopyright} 2021 The Author(s) Copyright: Copyright 2021 Elsevier B.V., All rights reserved.",
year = "2021",
month = mar,
doi = "10.1016/j.euros.2021.01.005",
language = "English",
volume = "25",
pages = "39--43",
journal = "European Urology Open Science ",
issn = "2666-1683",
publisher = "Elsevier",

}

RIS

TY - JOUR

T1 - Major urological cancer surgery for patients is safe and surgical training should be encouraged during the COVID-19 pandemic

T2 - A multi-centre analysis of 30-day outcomes

AU - Tan, Wei Shen

AU - Arianayagam, Ranjan

AU - Khetrapal, Pramit

AU - Rowe, Edward

AU - Kearley, Samantha

AU - Mahrous, Ahmed

AU - Pal, Raj

AU - Fowler, William

AU - Heer, Rakesh

AU - Elajnaf, Mohamed

AU - Douglas-Moore, Jayne

AU - Griffiths, TR Leyshon

AU - Voss, James

AU - Wilby, Daniel

AU - Al Kadhi, Omar

AU - Noel, Jonathan

AU - Vasdev, Nikhil

AU - McKay, Alastair

AU - Ahmad, Imran

AU - Abu-Nayla, Islam

AU - Lamb, Benjamin

AU - Hill, George T

AU - Narahari, Krishna

AU - Kynaston, Howard

AU - Yousuf, Arzu

AU - Kusuma, Venkata RM

AU - Cresswell, Joanne

AU - Cooke, Pete

AU - Chakravarti, Aniruddha

AU - Barod, Ravi

AU - Bex, Axel

AU - Kelly, John D

N1 - Funding Information: Funding/Support and role of the sponsor: Wei Shen Tan is funded by the Urology Foundation . Publisher Copyright: © 2021 The Author(s) Copyright: Copyright 2021 Elsevier B.V., All rights reserved.

PY - 2021/3

Y1 - 2021/3

N2 - COVID-19 has resulted in the deferral of major surgery for genitourinary (GU) cancers with the exception of cancers with a high risk of progression. We report outcomes for major GU cancer operations, namely radical prostatectomy (RP), radical cystectomy (RC), radical nephrectomy (RN), partial nephrectomy (PN), and nephroureterectomy performed at 13 major GU cancer centres across the UK between March 1 and May 5, 2020. A total of 598 such operations were performed. Four patients (0.7%) developed COVID-19 postoperatively. There was no COVID-19–related mortality at 30 d. A minimally invasive approach was used in 499 cases (83.4%). A total of 228 cases (38.1%) were described as training procedures. Training case status was not associated with a higher American Society of Anesthesiologists (ASA) score (p = 0.194) or hospital length of stay (LOS; p > 0.05 for all operation types). The risk of contracting COVID-19 was not associated with longer hospital LOS (p = 0.146), training case status (p = 0.588), higher ASA score (p = 0.295), or type of hospital site (p = 0.303). Our results suggest that major surgery for urological cancers remains safe and training should be encouraged during the ongoing COVID-19 pandemic provided appropriate countermeasures are taken. These real-life data are important for policy-makers and clinicians when counselling patients during the current pandemic. Patient summary: We collected outcome data for major operations for prostate, bladder, and kidney cancers during the COVID-19 pandemic. These surgeries remain safe and training should be encouraged during the ongoing pandemic provided appropriate countermeasures are taken. Our real-life results are important for policy-makers and clinicians when counselling patients during the COVID-19 pandemic.

AB - COVID-19 has resulted in the deferral of major surgery for genitourinary (GU) cancers with the exception of cancers with a high risk of progression. We report outcomes for major GU cancer operations, namely radical prostatectomy (RP), radical cystectomy (RC), radical nephrectomy (RN), partial nephrectomy (PN), and nephroureterectomy performed at 13 major GU cancer centres across the UK between March 1 and May 5, 2020. A total of 598 such operations were performed. Four patients (0.7%) developed COVID-19 postoperatively. There was no COVID-19–related mortality at 30 d. A minimally invasive approach was used in 499 cases (83.4%). A total of 228 cases (38.1%) were described as training procedures. Training case status was not associated with a higher American Society of Anesthesiologists (ASA) score (p = 0.194) or hospital length of stay (LOS; p > 0.05 for all operation types). The risk of contracting COVID-19 was not associated with longer hospital LOS (p = 0.146), training case status (p = 0.588), higher ASA score (p = 0.295), or type of hospital site (p = 0.303). Our results suggest that major surgery for urological cancers remains safe and training should be encouraged during the ongoing COVID-19 pandemic provided appropriate countermeasures are taken. These real-life data are important for policy-makers and clinicians when counselling patients during the current pandemic. Patient summary: We collected outcome data for major operations for prostate, bladder, and kidney cancers during the COVID-19 pandemic. These surgeries remain safe and training should be encouraged during the ongoing pandemic provided appropriate countermeasures are taken. Our real-life results are important for policy-makers and clinicians when counselling patients during the COVID-19 pandemic.

KW - COVID-19

KW - Cystectomy

KW - Mortality

KW - Nephrectomy

KW - Outcomes

KW - Prostatectomy

UR - http://www.scopus.com/inward/record.url?scp=85100443380&partnerID=8YFLogxK

U2 - 10.1016/j.euros.2021.01.005

DO - 10.1016/j.euros.2021.01.005

M3 - Letter

C2 - 33458711

VL - 25

SP - 39

EP - 43

JO - European Urology Open Science

JF - European Urology Open Science

SN - 2666-1683

ER -